Real-time enrollment status for this primary immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:23 PM UTC
| NCT Number | NCT05070845 |
| Recruiting Status | Recruiting |
| Condition | Primary Immune Thrombocytopenia |
| Phase | Clinical Trial |
| Target Enrollment | 91 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | May 12, 2026 (May 12, 2026) |
As of July 13, 2026: Clinical trial NCT05070845 is currently recruiting participants. This clinical trial study for primary immune thrombocytopenia is actively seeking new participants at 1 location across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05070845 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05070845 was last updated May 12, 2026 (May 12, 2026). HelloStudys verifies this status automatically.